Upcoming events

Latest news

  • eTheRNA and China Grand Pharma enter a strategic collaboration in the Greater China Region focussed on eTheRNA’s proprietary mRNA development products and manufacturing capabilities

    14 hours ago

  • AbolerIS Pharma signed with Ouest Valorisation an exclusive world-wide license to develop new first-in-class anti-CD45RC monoclonal antibodies

    14 hours ago

  • Galapagos reports positive topline results with GLPG1205 in IPF patients in PINTA Proof-of-Concept trial

    1 day ago